Proactive Investors - Run By Investors For Investors

G Medical Innovations a leading gainer on news of proposed Hong Kong listing of Chinese subsidiary

The shares were up 60% to an intra-day high of 29.7 cents on volume of more than 4.5 million.
ASX chart with arrow pointing up
The company specialises in mobile and e-health solutions and services

G Medical Innovations Holdings Ltd (ASX:GMV) is a leading ASX gainer on news of its intention to list its Chinese subsidiary on the main board of The Stock Exchange of Hong Kong Limited.

Shares were up 60% to an intra-day high of 29.7 cents on strong volume of more than 4.5 million.

Global investment bank engaged

The company has engaged global investment bank, UOB Kay Hian (Hong Kong) Ltd, as advisers for the listing of Guangzhou Yimei Innovative Medical Science and Technology Co Ltd (GYIMSTC).

Under the proposed listing, GYIMSTC would spin off from G Medical, with the ASX-listed company to retain not less than a 50% ownership stake.

The parent company currently holds 70% of GYIMSTC.

Intended listing in six to nine months

All parties are working towards a listing within the next six to nine months.

GYIMSTC oversees China-based manufacturing for G Medical, ensures all local certifications are met and has worked to build a strong relationship with the China Food and Drug Administration (CFDA).

It was the first company in 2018 to be granted acceptance to the Green Channel expedited Guangdong Provincial CFDA regulatory approval process.

Proven performer in China

This process was successfully applied to G Medical’s Prizma Medical Smartphone Case and will play a crucial role in the global commercialisation of this product.

Future innovative medical solutions in the development pipeline should also benefit from this process.

Funds raised from the listing will provide substantial working capital and fuel the research and development of innovative mobile health solutions and enable continued investment into state-of-the-art manufacturing facilities.

G Medical specialises in innovative next-generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams.

View full GMV profile View Profile

G Medical Innovations Holdings Ltd Timeline

Related Articles

iphone with apps
May 16 2019
The California-based telehealth company is seeking to raise $6 million to scale up its proprietary platform over the next 60 to 90 days
plasma torch
May 03 2019
PyroGenesis harnesses the unique properties of thermal plasma to melt and transform metal, carry out high temperature chemical reactions and convert waste into energy
G Medical's Prizma device
January 22 2019
The mobile and e-health company is set for first production from its facility in Guangzhou, China.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use